An approach to the understanding of the nasal early-phase reaction induced by nasal allergen challenge

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 52, Issue 2, 1997, Pages 162-167

  Wang, D ^a,b   Smitz, J ^a   Waterschoot, S ^a   Clement, P ^a  

^a UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

^b GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Early phase reaction; Mediators; Nasal allergen challenge; Nasal secretions; Nasal symptoms

Indexed keywords

HISTAMINE; LEUKOTRIENE C4; TRYPTASE;

ADULT; ALLERGIC RHINITIS; ARTICLE; CLINICAL ARTICLE; FEMALE; HUMAN; MALE; NOSE OBSTRUCTION; NOSE SECRETION; PRIORITY JOURNAL; RHINORRHEA;

EID: 0030933307     PISSN: 01054538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1398-9995.1997.tb00970.x     Document Type: Article

References (23)

1. Dahl R. Early- and late-phase reaction in the bronchi and the nose. In: Mygind N, Pipkorn U, Dahl R, editors. Rhinitis and asthma. Copenhagen: Munksgaard, 1990:203-12.
2. Naclerio RM, Meier HL, Kagey-Sobotka A, et al. Mediator release after nasal airway challenge with allergen. Am Rev Respir Dis 1983;128:597-602.
3. Naclerio RM, Proud D, Togias AG, et al. Inflammatory mediator in late antigen-induced rhinitis. N Engl J Med 1985;313:65-70.
4. Juliusson S, Holmberg K, Baumgarten CR, Olsson M, Enander I, Pipkorn U. Tryptase in nasal lavage fluid after local allergen challenge. Allergy 1991;46:459-65.
5. Rasp G, Hochstrasser K. Tryptase in nasal fluid is a useful marker of allergic rhinitis. Allergy 1993;48:72-4.
6. 4 and histamine in nasal lavage fluid. In: Mygind N, Pipkorn U, editors. Allergic and vasomotor rhinitis: pathophysiological aspects. Copenhagen: Munksgaard, 1987:189-97.
7. Creticos PS, Peters SP, Adkinson NF, Naclerio RM, Norman PS, Lichtenstein LM. Peptide leukotriene release after antigen challenge in patients sensitive to ragweed. N Engl J Med 1984;310:1626-30.
8. Wang DY, Clement P, Smitz J, De Waele M, Derde M-P. Correlations between complaints, inflammatory cells and mediators after nasal allergen challenge and during natural allergen exposure. Int Arch Allergy Immunol 1995; 106:278-85.
9. Biewenga J, Stoop AE, Baker HE, et al. Nasal secretions from patients with polyps and healthy individuals, collected with a new aspiration system: evaluation of total protein and immunoglobulin concentrations. Ann Clin Biochem 1991;28:260-6.
10. Wang DY, Clement P, Smitz J, Derde M-P. Concentrations of chemical mediators in the nasal secretions after nasal allergen challenge in atopic patients. Eur Arch Otorhinolaryngol 1995;252 Suppl:S40-3.
11. Clement PAR, van Dishoeck A, van de Wal J, Stoop P, Hoek T, van Strick R. Nasal provocation and passive anterior rhinomanometry (PAR). Clin Allergy 1981;11:293-301.
12. Knani J, Campbell A, Enander I, Peterson CGB, Michel F-B, Bousquet J. Indirect evidence of nasal inflammation assessed by titration of inflammatory mediators and enumeration of cells in nasal secretions of patients with chronic rhinitis. J Allergy Clin Immunol 1992;90:881-9.
13. Gerth van Wijk R, Dieges PH. Comparison of nasal responsiveness to histamine, methacholine and phentolamine in allergic rhinitis patients and controls. Clin Allergy 1987;17:563-70.
14. Wang DY, Clement P, Smitz J, Derde M-P. Concentrations of chemical mediators in nasal secretions of patients with hay fever during natural allergen exposure. Acta Otolaryngol (Stockh) 1994;114:552-5.
15. Grønborg H, Bisgaard H, Rømeling F, Mygind N. Early and late nasal symptom response to allergen challenge. The effect of pretreatment with a glucocorticosteroid spray. Allergy 1993;48:87-93.
16. Mygind N. Pathophysiology of allergic rhinitis. Eur Respir Rev 1994;4:248-51.
17. Wang D, Clement P. Assessment of early and late phase nasal obstruction in atopic patients after nasal allergen challenge. Clin Otolaryngol 1995;20:368-73.
18. Wang D, Clement P, Smitz J, De Waele M. The activity of recent anti-allergic drugs in the treatment of seasonal allergic rhinitis. Acta Otorhinolaryngol Belg 1996;50: 25-32.
19. Naclerio RM, Proud D, Kagey-Sobotka A, Freidhoff L, Norman PS, Lichtenstein LM. The effect of cetirizine on early allergic response. Laryngoscope 1989;99:596-9.
20. Wang D, Clement P, Smitz J, Derde M-P. Relevance of histamine and tryptase concentrations in nasal secretions after nasal challenges with phosphate buffered saline and allergen. Med Inflamm 1994;5:98-102.
21. Spector SL. Leukotriene inhibitors and antagonists in asthma. J Allergy Clin Immunol 1995;75 (Part 1): 463-71.
22. Raphael GD, Meredith SD, Baraniuk JN, Druce HM, Banks SM, Kaliner MA. The pathophysiology of allergic rhinitis. II. Assessment of the sources of protein in histamine-induced nasal secretions. Am Rev Respir Dis 1989;139:791-800.
23. Baraniuk J, Kaliner A. Functional activity of upper-airway nerves. In: Busse WW, Holgate ST, editors. Asthma and rhinitis. Boston: Blackwell Scientific, 1995:652-66.